Skip to main content

Alnylam Pharmaceuticals is responsible for the funding and content of this website. The site is intended for the general public in Europe, Middle East and Africa for disease awareness purposes only. Nothing on the site constitutes individual medical advice. Individuals are advised to consult their physician or other appropriate HCP. PH1-INTX-00068 | April 2025

Living with PH1 Homepage
  • ABOUT PH1
  • MANAGEMENT
  • LIVING WITH PH1
  • SUPPORT
  • BEHANDLUNGS-ZENTREN
  • PARENTS & CAREGIVERS

Impressum

FIRMENANSCHRIFT: ALNYLAM GERMANY GMBHMaximilianstrasse 35a, 80539 München Tel.: +49 89 20190100 Internet: www.alnylam.de Mail: info@alnylam.de GESCHÄFTSFÜHRUNG: Hannes Schmeil, David Jones AUFSICHTSBEHÖRDE: Regierung von Oberbayern, Maximilianstraße 39, 80538 München HANDELSREGISTER: Amtsgericht München HRB 224597 UST.ID.-NUMMER: DE 306 994 049 KONTAKT: Hannes SchmeilAlnylam Germany GmbHMaximilianstrasse 35a80539 München Tel.: +49 89 20190100Mail: info@alnylam.de
container links

You are now leaving LivingWithPH1.eu

Links to all outside sites are provided as a reference for our visitors. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Visit Site Back to Homepage

Could it be Primary Hyperoxaluria Type 1 (PH1)?

Take this short survey to find out if you should be tested for PH1.

Get started

Alnylam Pharmaceuticals Logo

  • HOME
  • ABOUT PH1
  • MANAGEMENT
  • LIVING WITH PH1
  • SUPPORT
  • BEHANDLUNG-SZENTREN
  • PARENTS & CAREGIVERS

LivingWithPH1 is a trademark of Alnylam Pharmaceuticals, Inc.
©2025 Developed and produced by Alnylam Switzerland GmbH. All rights reserved.

  • Privacy Policy
  • Legal Notice
  • Contact Us
  • Site Map
  • Impressum
PH1-INTX-00068 | April 2025